Pirfenidone Use in Asbestosis Patients: Efficacy and Prognosis
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Clinical Trials Related to Pirfenidone
Related studies linked through entity extraction aliases.
Pirfenidone to Prevent Fibrosis in Ards.
- Status
- RECRUITING
- Phase
- PHASE3
Phase ll Study of HEC585 in Patients With IPF
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Drug-drug Interaction Study with GLPG4716 and Nintedanib and Pirfenidone in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Immunosuppressant Combined With Pirfenidone in CTD-ILD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
To Evaluate Drug-drug Interactions Between DWN12088 and Pirfenidone or Nintedanib in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Pirfenidone vs. Nintedanib for Fibrotic Lung Disease After Coronavirus Disease-19 Pneumonia
- Status
- UNKNOWN
- Phase
- PHASE4
Treatment With Pirfenidone for COVID-19 Related Severe ARDS
- Status
- COMPLETED
- Phase
- NA
Pirfenidone Compared to Placebo in Post-COVID19 Pulmonary Fibrosis COVID-19
- Status
- UNKNOWN
- Phase
- PHASE2
Examination of Pirfenidone (Esbriet®) Therapy in Coal Workers' Pneumoconiosis With Pulmonary Fibrosis
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus Infection
- Status
- UNKNOWN
- Phase
- PHASE3
Trial of Pirfenidone to Prevent Progression in Chronic Kidney Disease
- Status
- UNKNOWN
- Phase
- PHASE2
Efficacy and Safety of Pirfenidone Treatment in HPS-ILD
- Status
- UNKNOWN
- Phase
- PHASE2
Pirfenidone and Advanced Liver Fibrosis.
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Pharmacokinetic Interaction Between Pirfenidone and BMS-986278 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study Based on Medical Records That Looks at the Characteristics of Idiopathic Pulmonary Fibrosis Patients Grouped by the Type of Medication They Are Taking
- Status
- COMPLETED
- Phase
- N/A
A Study About Safety and Efficacy of Pirfenidone to Treat Grade 2 or Grade3 Radiation-induced Lung Injury.
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Pirfenidone in Patient With Dermatomyositis Interstitial Lung Disease (Dm-ILD)
- Status
- UNKNOWN
- Phase
- PHASE3
Efficacy and Safety of Pirfenidone in Patient With Systemic Sclerosis-associated Interstitial Lung Disease
- Status
- UNKNOWN
- Phase
- PHASE3
Pilot Study of Pirfenidone in Pulmonary Fibrosis With Anti-myeloperoxydase Antibodies
- Status
- COMPLETED
- Phase
- PHASE2